AtriCure, Inc. (ATRC) vs Stevanato Group S.p.A. (STVN)
- AtriCure, Inc. ATRC 56.09 −2.92%
- Stevanato Group S.p.A. STVN 18.90 −1.82%
AtriCure, Inc. and Stevanato Group S.p.A. are both Medical Instruments & Supplies companies. Stevanato Group S.p.A. is the larger, with a market value of $5.3B against $2.9B — 1.8× the size. Stevanato Group S.p.A. trades at the lower P/E: 33.8× against 259×. Stevanato Group S.p.A. grew revenue faster over the last twelve months: 14.3% against 13.9%. Stevanato Group S.p.A. has the higher net margin (11.0% vs 1.85%) and the higher return on invested capital (6.56% vs 1.92%). Across the 21 metrics below, Stevanato Group S.p.A. leads on 13 and AtriCure, Inc. on 8.
Valuation
Profitability
| Metric | ATRC | STVN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.30% | 29.13% | 54.29% |
| Operating margin | 2.26% | 16.29% | 1.07% |
| Net margin | 1.85% | 10.95% | (1.61%) |
| Free cash flow margin | 9.32% | (2.43%) | 1.08% |
| Return on equity | 2.15% | 9.21% | (1.32%) |
| Return on assets | 1.64% | 5.46% | 0.00% |
| Return on invested capital | 1.92% | 6.56% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack